Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)

SHE:002252 Revenue

Shanghai RAAS Blood Products had revenue of 2.06B CNY in the quarter ending September 30, 2024, with 1.34% growth. This brings the company's revenue in the last twelve months to 8.34B, up 10.49% year-over-year. In the year 2023, Shanghai RAAS Blood Products had annual revenue of 7.96B with 21.27% growth.

• Revenue (ttm): 8.34B
• Revenue Growth: +10.49%
• P/S Ratio: 5.38
• Revenue / Employee: 2.56M
• Employees: 3,254
• Market Cap: 44.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.96B	1.40B	21.27%
Dec 31, 2022	6.57B	2.28B	53.16%
Dec 31, 2021	4.29B	1.53B	55.26%
Dec 31, 2020	2.76B	176.70M	6.84%
Dec 31, 2019	2.58B	780.75M	43.27%